UPDATE : Wednesday, September 18, 2019
상단여백
FIP head calls for revitalizing generic substitution by Lee Hye-seon 2017-09-12 14:34
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share by Marian Chu 2017-09-12 13:26
Sillajen stock surges upon clinical trial announcement by Lee Han-soo 2017-09-12 13:26
Ildong, Olix agree to develop new drugs by Lee Han-soo 2017-09-11 17:30
Abbvie lands 1st place on Dow Jones Sustainability Index by Marian Chu 2017-09-11 14:38
라인
GSK’s HIV drug ranked No. 1 in Q2 sales by Marian Chu 2017-09-11 14:37
FDA orders halt on Opidvo trials by Marian Chu 2017-09-08 16:39
Vivus, Alvogen sign agreement to market diet treatment in Korea by Lee Han-soo 2017-09-08 15:24
Teva-Handok wins approval for anti-asthma injection by Marian Chu 2017-09-07 14:58
Novartis Korea gains approval for skin disease biologic by Marian Chu 2017-09-07 14:28
라인
Green Cross Cell, Maryland to cooperate for US business by Lee Han-soo 2017-09-07 11:18
BMS, Pfizer prove safety for blood-thinning drug in P4 trial by Marian Chu 2017-09-06 17:40
Novartis’ Revolade proved effective for seniors by Marian Chu 2017-09-06 12:53
GemVax & KAEL names Song as new CEO by Lee Han-soo 2017-09-06 10:47
Will Amgen’s Repatha succeed in the Korean market? by Marian Chu 2017-09-06 09:07
라인
Pfizer Korea releases new tool for rheumatism injection by Marian Chu 2017-09-05 17:22
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks by Nam Doo-hyun 2017-09-05 16:45
Celgene Korea names new CEO by Marian Chu 2017-09-05 14:22
Korean start-up Sky Labs wins in Bayer innovation program by Marian Chu 2017-09-05 11:11
Ahngook gets state support for new drug by Lee Han-soo 2017-09-05 10:53
여백
여백
여백
Back to Top